—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Bristol-Myers Squibb Company (BMY) — Technical state

As of 2026-11-05 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +1.3% vs the 50-day and +5.4% vs the 200-day average, 8% below the 52-week high and +42.6% off the 52-week low. Computed from daily closes. (as of 2026-11-05)
  • Trend: Bristol-Myers Squibb Company trades 1.3% above its 50-day and 5.4% above its 200-day moving average. (as of 2026-11-05)

Bristol-Myers Squibb researches, makes and sells prescription medicines worldwide, covering cancer, blood disorders, immune disease, heart disease and brain conditions. Its portfolio spans older blockbuster drugs such as Eliquis and Revlimid alongside newer immuno-oncology and cell-therapy treatments like Opdivo and Breyanzi, plus recent launches in psoriasis, schizophrenia and lung cancer.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BMY overview. Research diary readings, not advice.

Uptrend stack intact

Trades +1.3% vs the 50-day and +5.4% vs the 200-day average, 8% below the 52-week high and +42.6% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the BMY chart & overview · the signal board

FAQ · from the current data · as of 2026-11-05

Quick answers

What is the current Closelooknet signal on BMY?

Uptrend stack intact — Trades +1.3% vs the 50-day and +5.4% vs the 200-day average, 8% below the 52-week high and +42.6% off the 52-week low. Computed from daily closes. As of 2026-11-05; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is BMY above its 50-day and 200-day moving averages?

As of 2026-11-05, Bristol-Myers Squibb Company trades +1.3% above its 50-day and +5.4% above its 200-day average, with the 20-day +3.6% away.

How far is BMY from its 52-week high?

8% below the 52-week high and 42.6% above the 52-week low, as of 2026-11-05.

Mentioned on Closelooknet

Where BMY appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.